Dermapharm Holding SE/ DE000A2GS5D8 /
6/3/2024 7:57:07 AM | Chg. +0.3500 | Volume | Bid8:20:46 AM | Ask8:20:46 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
36.8500EUR | +0.96% | - Turnover: - |
36.7500Bid Size: 100 | 36.9500Ask Size: 100 | 1.94 bill.EUR | 2.44% | 31.12 |
GlobeNewswire
8:30 AM
Orion is developing the Finnish life science industry in a unique collaboration project
GlobeNewswire
8:01 AM
Flash News: OKX Announces Adjustments to Minimum Order Quantities for Select Futures Listings
GlobeNewswire
8:00 AM
FTI Consulting Adds Senior Chemicals Industry Expert to Further Expand Business Transformation Pract...
GlobeNewswire
8:00 AM
Caledonia to file preliminary economic assessment on chosen approach to develop the Bilboes sulphide...
GlobeNewswire
8:00 AM
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire
7:48 AM
Flash News: OKX Announces Enhancements to Portfolio Margin Mode to Optimize Trading Experience
GlobeNewswire
7:30 AM
Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)
GlobeNewswire
7:30 AM
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead C...
GlobeNewswire
6:00 AM
BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Disease...
GlobeNewswire
5:01 AM
AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences